The other GLP-1 peptide demonstrated to have clinical potential for type 2 diabetes was GLP-1 (7-36)
doi: 10.1136/bcr-2020-235663
FIGURE 1 2 Defining underexplored peptidereceptor systems In the context of peptide drug discovery, the term underexplored is often used imprecisely to denote novelty, obscurity, or a lack of published literature
demonstrate their commitment to product quality through extensive infrastructure investments including specialized cold storage facilities, advanced analytical testing capabilities, and validated packaging systems that maintain pharmaceutical-grade integrity from production through final delivery to customers worldwide
That said, there are a few aging-related risks to understand before starting weight loss medications like Wegovy or Zepbound, including: Fall risk due to lost muscle mass Underdiagnosed hypoglycemia Nutritional deficiencies One of the biggest risks of GLP-1 agonist medications in the elderly population is loss of muscle mass because any weight loss will lead to loss of muscle mass, says Cynthia Odogwu, MD, a family and lifestyle medicine physician in Maryland
Wang N, Gao J, Jia M, Ma X, Lei Z, Da F, Yan F, Zhang H, Zhou Y, Li M